Publications
199
Citations
5,827
Est. group size
~4
Recurring co-author estimate
Active years
44
Publishing since 1983
Rachid Drissi studies pediatric brain tumors, particularly high-grade glioma and diffuse intrinsic pontine glioma (a hard-to-treat childhood brainstem tumor), focusing on telomeres (protective structures at the ends of chromosomes) and the enzyme telomerase, DNA repair, and immune-based treatment strategies. Recent work combines laboratory studies of tumor biology (such as the protein BMI-1 and immune cell recruitment) with clinical trial efforts testing targeted drugs, immunotherapy, and telomere-targeting therapies in children. Note that one listed publication on financial risk modeling (Lévy-Flow Models) appears unrelated to this PI's core research area and may reflect a data or author-matching error.
Publication output has been variable over the last decade, with a notable spike in 2023 followed by fluctuating but generally steady activity in recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Lévy-Flow Models: Heavy-Tail-Aware Normalizing Flows for Financial Risk Management
arXiv (Cornell University) · 2026
- Lévy-Flow Models: Heavy-Tail-Aware Normalizing Flows for Financial Risk Management
arXiv (Cornell University) · 2026
- Integrated Multi-Omics Identifies Lineage-Dependent Myeloid Cells Recruitment and the APP-CD74 Axis as an Immunoregulatory Target in Pediatric High-Grade Glioma
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- <i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric Medulloblastoma
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- ID #1132 CONNECT TarGeT-A molecularly-guided phase 2 trial for children and young adults newly diagnosed with high-grade glioma (HGG), including diffuse intrinsic pontine glioma (DIPG): (1) Ribociclib and everolimus for HGG/DIPG with cell cycle and/or PI3K/mTOR pathway alterations, and (2) Ribociclib and temozolomide for diffuse hemispheric glioma (DHG), H3G34-mutant
Neuro-Oncology Pediatrics · 2026
- ID #1122 Preliminary feasibility of an international, multidisciplinary central screening platform for the CONNECT TarGeT molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG)
Neuro-Oncology Pediatrics · 2026
- ID #155 CONNECT TarGeT-H Phase 1/2 Clinical Study of a Novel Telomere-Targeting Therapy for Pediatric High-Grade Glioma (HGG) including Diffuse Intrinsic Pontine Glioma (DIPG) Harboring Telomerase Activation
Neuro-Oncology Pediatrics · 2026
- Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
Neuro-Oncology Advances · 2025
- <scp>BMI</scp> ‐1 modulation and trafficking during <scp>M</scp> phase in diffuse intrinsic pontine glioma
FEBS Open Bio · 2025
- BMI-1 Modulation and Trafficking During M Phase in Diffuse Intrinsic Pontine Glioma
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Author response for "BMI-1 modulation and trafficking during M phase in diffuse intrinsic pontine glioma"
2025
- DMG-24. Determining the role of BMI-1 in diffuse intrinsic pontine glioma during M phase
Neuro-Oncology Pediatrics · 2025
- DMG-22. Induced telomere damage and cell cycle checkpoint blockade: a novel approach for radiosensitization and immunomodulation to treat diffuse midline glioma
Neuro-Oncology Pediatrics · 2025
- DMG-25. Deciphering the role of macrophages in diffuse intrinsic pontine glioma: an insight into MHCII-mediated immune modulation
Neuro-Oncology Pediatrics · 2025
- Neuro-Oncology×50
- Figshare×14
- Neuro-Oncology Pediatrics×6
- Acta Neuropathologica Communications×5
- Journal of Neuro-Oncology×5
- Maryam Fouladi
Medicine · The Ohio State University
- Jonathan L. Finlay
Medicine · The Ohio State University
- Margot Lazow
Medicine · The Ohio State University
- Daniel R. Boué
Medicine · The Ohio State University
- Ralph Salloum
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile